Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma-Reference-Cited by-同舟云学术

Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma

Published:1990-02 Issue:2 Volume:162 Page:427-429
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Patsner Bruce,Orr James W.,Mann William J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference7 articles.

1. The role of the CA 125 assay in the management of ovarian cancer;Niloff;Oncology,1988

2. Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium, and endocervix;Niloff;Am J Obstet Gynecol,1984

3. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial cardinoma;Patsner;Am J Obstet Gynecol,1988

4. use of serum CA 125 levels to monitor therapy of patients with advanced or recurrent endometrial carcinoma;Patsner;Eur J Gynecol Oncol,1989

5. A monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas;King;Cancer Res,1984

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between serum CA-125 level and recurrence in surgical stage I endometrial cancer patients;Journal of the Chinese Medical Association;2023-08-29

2. Ovarian, Uterine, and Vulvovaginal Cancers;Medical Clinics of North America;2023-03

3. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-02

4. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model;Technology in Cancer Research & Treatment;2023-01

5. Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer;Technology in Cancer Research & Treatment;2023-01